A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance

Oncogene

Volumn 23, Issue 3, 2004, Pages 744-752

  Whiteside, Martin A ^a   Chen, Dung Tsa ^b   Desmond, Renee A ^b   Abdulkadir, Sarki A ^c   Johanning, Gary L ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Drug resistance; Gene expression profiling; Lung cancer; Mechanisms of drug action

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA;

ARTICLE; CANCER CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; DRUG MEGADOSE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IC 50; LUNG CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; CISPLATIN; DNA PRIMERS; DNA, COMPLEMENTARY; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 1242340503     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207164     Document Type: Article

References (34)

1. Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA and Holt JT. (1999). J. Biol. Chem., 274, 18808-18812.
2. Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC and Fornace Jr AJ. (2000). Cancer Res., 60, 6101-6110.
3. Anderson IC, Sugarbaker DJ, Ganju RK, Tsarwhas DG, Richards WG, Sunday M, Kobzik L and Shipp MA. (1995). Cancer Res., 55, 4120-4126.
4. Anderson KM, Alrefai WA, Anderson CA, Ho Y, Jadko S, Ou D, Wu Y-B and Harris JE. (2002). Anticancer Res., 22, 75-82.
5. Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR and Bishop DK. (2000). J. Biol. Chem., 275, 23899-23903.
6. Bolon I, Devouassoux M, Robert C, Moro D, Brambilla C and Brambilla E. (1997). Am. J. Pathol., 150, 1619-1629.
7. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM and Breit SN. (1997). Proc. Natl. Acad. Sci. USA, 94, 11514-11519.
8. Boulay A, Masson R, Chenard MP, El Fahime M, Cassard L, Bellocq JP, Sautes-Fridman C, Basset P and Rio MC. (2001). Cancer Res., 61, 2189-2193.
9. Brognard J, Clark AS, Ni Y and Dennis PA. (2001). Cancer Res., 61, 3986-3997.
10. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S and Nakshatri H. (2001). J. Biol. Chem., 276, 9817-9824.
11. Citri A, Skaria KB and Yarden Y. (2003). Exp. Cell Res., 284, 54-65.
12. Clave E, Carosella ED, Gluckman E and Socie G. (1997). Leukemia, 11, 114-119.
13. Dabholkar M, Bostick-Bruton F, Weber C, Bohr VA, Egwuagu C and Reed E. (1992). J. Natl. Cancer Inst., 84, 1512-1517.
14. Dan S, Tsunoda T, Kitahara O, Yanagawa R, Zembutsu H, Katagiri T, Yamazaki K, Nakamura Y and Yamori T. (2002). Cancer Res., 62, 1139-1147.
15. De Larco JE, Wuertz BR, Manivel JC and Furcht LT. (2001). Cancer Res., 61, 2857-2861.
16. Delebecq TJ, Porte H, Zerimech F, Copin MC, Gouyer V, Dacquembronne E, Balduyck M, Wurtz A and Huet G. (2000). Clin. Cancer Res., 6, 1086-1092.
17. Dunkern TR, Fritz G and Kaina B. (2001). Mutat. Res., 486, 249-258.
18. Henderson YC, Chou M and Deisseroth AB. (1997). Br. J. Haematol., 96, 566-575.
19. Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS and Chin K-V. (2000). Cancer Res., 60, 4161-4166.
20. Lai WW, Chen FF, Wu MH, Chow NH, Su WC, Ma MC, Su PF, Chen H, Lin MY and Tseng YL. (2001). Ann. Thorac. Surg., 72, 1868-1876.
21. Lamendola DE, Duan Z, Yusuf RZ and Seiden MV. (2003). Cancer Res., 63, 2200-2205.
22. Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I and Lee JH. (2003). Cancer Res., 63, 4648-4655.
23. Li Q, Yu JJ, Mu C, Yunmbam MK, Slavsky D, Cross CL, Bostick-Bruton F and Reed E. (2000). Anticancer Res., 20, 645-652.
24. Mousses S, Wagner U, Chen Y, Kim JW, Bubendorf L, Bittner M, Pretlow T, Elkahloun AG, Trepel JB and Kallioniemi OP. (2001). Oncogene, 20, 6718-6723.
25. Moynahan ME, Chiu JW, Koller BH and Jasin M. (1999). Mol. Cell., 4, 511-518.
26. Munster PN, Marchion DC, Basso AD and Rosen N. (2002). Cancer Res., 62, 3132-3137.
27. Noel AC, Lefebvre O, Maquoi E, VanHoorde L, Chenard MP, Marcel M, Foidart JM, Basset P and Rio MC. (1996). J. Clin. Invest., 97, 1924-1930.
28. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn Jr PA, Carney D, Minna JD and Mulshine JL. (1996). J. Cell. Biochem., 24 (Suppl.), 32-91.
29. Plumb JA, Milroy R and Kaye SB. (1989). Cancer Res., 49, 4435-4440.
30. Rajeevan MS, Ranamukhaarachchi DG, Vernon SD and Unger ER. (2001). Methods, 25, 443-451.
31. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO and Weinstein JN. (2000). Nat. Genet., 24, 236-244.
32. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ and Qin J. (2000). Genes Dev., 14, 927-939.
33. Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, Sutherland RL, Breit SN, Moskaluk CA, Frierson Jr HF and Hampton GM. (2003). Proc. Natl. Acad. Sci. USA, 100, 3410-3415.
34. Zhang J and Byrne CD. (1999). Biochem. J., 337 (Part 2), 231-241.